Clinical Trial Experts to Discuss Relationship Between “Big Data” and Strategic CRO and Clinical Trial Sponsor Partnerships

Panel at DIA Annual Meeting to Explore Leveraging Data and Analytics to Enhance Collaboration

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friendRepost This

dia 50 anniversary

The meeting will provide the forum to address how the wealth of new data and enhanced analytics can strengthen partnerships between these vital organizations to intelligently approach clinical trial planning and execution.

Washington (PRWEB) April 18, 2014

The impact of “big data” on the partnerships between contract research organizations (CROs) and clinical trial sponsors will be discussed at the DIA 2014 50th Annual Meeting, June 15 to 19, in San Diego. The “Big Data, Big Impact: New Levels of Strategic Partnerships Between Sponsors-CROs” forum, held on June 17 at 8 a.m. in the San Diego Convention Center, will bring together those working in CROs and their sponsor partners to explore how increased collaboration within today’s data-driven environment can expand capabilities by leveraging new discovery technologies, enhancing clinical trial efficiency and paving the way for clinical breakthroughs.

Big data—the storage and analysis of comprehensive medical, patient, payer and real-world health data sets—can revolutionize collaborations in the life science arenas.

“The meeting will provide the forum to address how the wealth of new data and enhanced analytics can strengthen partnerships between these vital organizations to intelligently approach clinical trial planning and execution and streamline the drug development process,” said Barbara L. Kunz, DIA global chief executive.

The session will be chaired by MaryAnne Rizk, an experienced partnerships and alliances professional and adjunct professor with Stevens Institute of Technology. The panel will feature Brendan Buckley, chief medical officer of ICON, and Gary Thompson, senior director of data sciences and solutions and biometric sourcing at Eli Lilly and Co.

ABOUT DIA: DIA is the global connector in the life sciences product development process. Our association of more than 18,000 members builds productive relationships by bringing together regulators, innovators and influencers to exchange knowledge and collaborate in an impartial setting. DIA’s network creates unparalleled opportunities for the exchange of knowledge and has the interdisciplinary experience to prepare for future developments. DIA is an independent, nonprofit organization with its global center in Washington, D.C., USA; regional offices covering North and South America (Horsham, Pa., USA); Europe, North Africa and the Middle East (Basel, Switzerland); and Japan (Tokyo), India (Mumbai) and China (Beijing). For more information, visit http://www.diahome.org.

ABOUT DIA’s 2014 50th ANNUAL MEETING: Celebrate the Past – Invent the Future is the largest multidisciplinary event that brings together a community of life sciences professionals at all levels and across all disciplines involved in the discovery, development and life cycle management of medical products. The meeting aims to foster innovation that will lead to the development of safe and effective medical products and therapies for patients. For more information, visit http://www.diahome.org/dia2014.


Contact